|
Volumn 52, Issue 8, 2008, Pages 672-673
|
Enrollment of Women in National Heart, Lung, and Blood Institute-Funded Cardiovascular Randomized Controlled Trials Fails to Meet Current Federal Mandates for Inclusion
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DEFIBRILLATOR;
FEMALE;
FINANCIAL MANAGEMENT;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HORMONE SUBSTITUTION;
HUMAN;
HYPERTENSION;
LETTER;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEX DIFFERENCE;
STROKE;
FEMALE;
HUMANS;
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.);
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH SUPPORT AS TOPIC;
UNITED STATES;
WOMEN;
|
EID: 48849103451
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2008.05.025 Document Type: Letter |
Times cited : (107)
|
References (10)
|